MedPath

Analyses of the skin molecules in patients with severe refractory asthma(2).

Not Applicable
Recruiting
Conditions
Bronchial asthma
Registration Number
JPRN-UMIN000036116
Lead Sponsor
Kao Corporation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

1.Panelists who have complications such as pneumonitis, infection, and cancer. 2.Panelists who have treated with antibody drugs except for dupilumab. 3.Panelists who are regarded as inappropriate in this study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The relationship between skin molecules and therapeutic effects in severe refractory asthma.
Secondary Outcome Measures
NameTimeMethod
The relationship of the molecules between skin and blood.
© Copyright 2025. All Rights Reserved by MedPath